Suppr超能文献

Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment.

作者信息

Sitbon Olivier, Bertoletti Laurent

机构信息

Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France. AP-HP, Centre de Référence de l'hypertension pulmonaire sévère, Service de pneumologie et soins intensifs, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. INSERM U-999, LabEx LERMIT, Centre chirurgical Marie Lannelongue, Le Plessis-Robinson, France. Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France. Université Jean-Monnet, Groupe de Recherche sur la Thrombose (EA 3065), Inserm, CIC1408, Saint-Etienne, France Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France. AP-HP, Centre de Référence de l'hypertension pulmonaire sévère, Service de pneumologie et soins intensifs, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. INSERM U-999, LabEx LERMIT, Centre chirurgical Marie Lannelongue, Le Plessis-Robinson, France. Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France. Université Jean-Monnet, Groupe de Recherche sur la Thrombose (EA 3065), Inserm, CIC1408, Saint-Etienne, France Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France. AP-HP, Centre de Référence de l'hypertension pulmonaire sévère, Service de pneumologie et soins intensifs, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. INSERM U-999, LabEx LERMIT, Centre chirurgical Marie Lannelongue, Le Plessis-Robinson, France. Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France. Université Jean-Monnet, Groupe de Recherche sur la Thrombose (EA 3065), Inserm, CIC1408, Saint-Etienne, France

Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France. AP-HP, Centre de Référence de l'hypertension pulmonaire sévère, Service de pneumologie et soins intensifs, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. INSERM U-999, LabEx LERMIT, Centre chirurgical Marie Lannelongue, Le Plessis-Robinson, France. Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France. Université Jean-Monnet, Groupe de Recherche sur la Thrombose (EA 3065), Inserm, CIC1408, Saint-Etienne, France Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France. AP-HP, Centre de Référence de l'hypertension pulmonaire sévère, Service de pneumologie et soins intensifs, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. INSERM U-999, LabEx LERMIT, Centre chirurgical Marie Lannelongue, Le Plessis-Robinson, France. Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France. Université Jean-Monnet, Groupe de Recherche sur la Thrombose (EA 3065), Inserm, CIC1408, Saint-Etienne, France.

出版信息

Eur Respir Rev. 2014 Dec;23(134):505-9. doi: 10.1183/09059180.00009214.

DOI:10.1183/09059180.00009214
PMID:25445949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9487410/
Abstract
摘要

相似文献

1
Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment.与肺动脉高压相关的结缔组织病：重度血流动力学损害患者的管理
Eur Respir Rev. 2014 Dec;23(134):505-9. doi: 10.1183/09059180.00009214.
2
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 1. Pulmonary hypertension associated with connective tissue diseases].[风湿性和结缔组织病中的严重器官损害及难治性临床病症——病理生理学与治疗进展。主题：二、需特别关注的临床病症；1. 结缔组织病相关肺动脉高压]
Nihon Naika Gakkai Zasshi. 2013 Oct 10;102(10):2613-20. doi: 10.2169/naika.102.2613.
3
[Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].[与弥漫性结缔组织病相关的重度（功能分级IV级）肺动脉高压患者的临床和血流动力学特征及治疗可能性]
Ter Arkh. 2015;87(5):24-32. doi: 10.17116/terarkh201587524-32.
4
[Pulmonary arterial hypertension in connective tissue diseases].[结缔组织病中的肺动脉高压]
Rev Mal Respir. 2006 Dec;23(6):746-8. doi: 10.1016/s0761-8425(06)72088-5.
5
Pulmonary hypertension in connective tissue diseases: an update.结缔组织病中的肺动脉高压：最新进展
Int J Rheum Dis. 2017 Jan;20(1):5-24. doi: 10.1111/1756-185X.13001. Epub 2017 Feb 16.
6
Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.评估与结缔组织病相关的肺动脉高压的终点。
Curr Opin Pulm Med. 2010 May;16 Suppl 1:S27-34. doi: 10.1097/01.mcp.0000370208.45756.e8.
7
[Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].[在合并结缔组织病的肺动脉高压患者中通过急性血管扩张试验比较腺苷与伊洛前列素]
Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2099-102.
8
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.结缔组织病相关肺动脉高压的免疫抑制治疗
Chest. 2006 Jul;130(1):182-9. doi: 10.1378/chest.130.1.182.
9
Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.特发性和结缔组织病相关性肺动脉高压患者的基线特征及生存率比较。
J Heart Lung Transplant. 2009 Jun;28(6):621-7. doi: 10.1016/j.healun.2009.02.016.
10
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.安立生坦在结缔组织病相关肺动脉高压（CTD-PAH）中的反应——ARIES-E临床试验的亚组分析。
Respir Med. 2016 Aug;117:254-63. doi: 10.1016/j.rmed.2016.06.018. Epub 2016 Jun 29.

引用本文的文献

1
Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.糖皮质激素联合环磷酰胺治疗血管扩张剂抵抗的混合性结缔组织病相关肺动脉高压
Intern Med. 2017;56(4):445-448. doi: 10.2169/internalmedicine.56.7668. Epub 2017 Feb 15.
2
Challenges in pulmonary hypertension: managing the unexpected.肺动脉高压的挑战：应对意外情况。
Eur Respir Rev. 2015 Dec;24(138):674-81. doi: 10.1183/16000617.0060-2015.
3
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation.重度肺动脉高压：治疗选择与移植过渡
Eur Respir Rev. 2014 Dec;23(134):488-97. doi: 10.1183/09059180.00007214.
4
New horizons in pulmonary arterial hypertension management.肺动脉高压管理的新视野
Eur Respir Rev. 2014 Dec;23(134):408-9. doi: 10.1183/09059180.00007614.

本文引用的文献

1
The role of combination therapy in managing pulmonary arterial hypertension.联合治疗在肺动脉高压管理中的作用。
Eur Respir Rev. 2014 Dec;23(134):469-75. doi: 10.1183/09059180.00007314. Epub 2014 Dec 1.
2
Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.肺动脉高压患者从静脉或皮下前列环素治疗转换为吸入曲前列尼尔治疗：一项回顾性病例系列研究
J Clin Pharm Ther. 2014 Oct;39(5):496-500. doi: 10.1111/jcpt.12170. Epub 2014 May 8.
3
Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus.成功运用强化免疫抑制疗法治疗一名系统性红斑狼疮患者同时出现的脑部病变和肺动脉高压。
Intern Med. 2014;53(6):627-31. doi: 10.2169/internalmedicine.53.0514.
4
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. upfront 三联疗法在肺动脉高压中的应用：一项初步研究。
Eur Respir J. 2014 Jun;43(6):1691-7. doi: 10.1183/09031936.00116313. Epub 2014 Mar 13.
5
Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study.恶性高血压病史患者的死亡率和心血管风险：一项病例对照研究。
J Clin Hypertens (Greenwich). 2014 Feb;16(2):122-6. doi: 10.1111/jch.12243. Epub 2013 Dec 27.
6
Updated treatment algorithm of pulmonary arterial hypertension.肺动脉高压的更新治疗方案。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D60-72. doi: 10.1016/j.jacc.2013.10.031.
7
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.《2014年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
8
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature.以重度肺动脉高压为首发表现的系统性红斑狼疮 1 例报告并文献复习
Clin Exp Rheumatol. 2014 Mar-Apr;32(2):267-74. Epub 2013 Dec 16.
9
Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl.11 岁女孩混合性结缔组织病相关肺动脉高压危象快速进展。
Eur J Pediatr. 2013 Sep;172(9):1263-5. doi: 10.1007/s00431-013-2034-3. Epub 2013 May 18.
10
Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.未选择病例的混合性结缔组织病患者群中肺动脉高压的流行率：一项全国性、挪威横断面多中心研究的结果及对当前文献的综述。
Rheumatology (Oxford). 2013 Jul;52(7):1208-13. doi: 10.1093/rheumatology/kes430. Epub 2013 Feb 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验